サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1170016

ヒトオリゴミルク糖 (HMO) の世界市場：分析・沿革・予測 (2017年～2028年)

Global Human Milk Oligosaccharides (HMO) Market Report, History and Forecast 2017-2028
出版日: | 発行: QYResearch | ページ情報: 英文 97 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
ヒトオリゴミルク糖 (HMO) の世界市場：分析・沿革・予測 (2017年～2028年)
出版日: 2022年12月09日
発行: QYResearch
ページ情報: 英文 97 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトオリゴミルク糖 (HMO) の市場規模は、2017年の8,373万米ドルから増加して、2021年には3億7,852万米ドル、2028年までに10億5,583万米ドルに達すると予測されています。

また、2022年から2028年の間に14.54%のCAGRで成長する見通しです。

当レポートでは、世界のヒトオリゴミルク糖 (HMO) の市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2017年～2028年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 ヒトオリゴミルク糖 (HMO)：市場概要

  • ヒトオリゴミルク糖 (HMO)：製品概要
  • 種類別の市場セグメント
    • 2'-FL、3-FL
    • シアリルラクトース、LNT、LNNTなど
  • 種類別の市場規模
    • 市場規模の概要：種類別 (2017年～2028年)
    • 過去の市場規模：種類別 (2017年～2022年)
    • 市場規模の予測：種類別 (2023年～2028年)
  • 主要地域の市場規模：種類別
    • 北米のヒトオリゴミルク糖 (HMO) の販売：種類別 (2017年～2022年)
    • 欧州のヒトオリゴミルク糖 (HMO) の販売：種類別 (2017年～2022年)
    • アジア太平洋のヒトオリゴミルク糖 (HMO) の販売：種類別 (2017年～2022年)

第2章 ヒトオリゴミルク糖 (HMO)：企業別の市場競争

  • 世界のヒトオリゴミルク糖 (HMO) の主要企業の販売 (2017年～2022年)
  • 世界のヒトオリゴミルク糖 (HMO) の主要企業の収益 (2017年～2022年)
  • 世界のヒトオリゴミルク糖 (HMO) の主要企業の価格 (2017年～2022年)
  • 主要メーカーの市場参入時期
  • 主要メーカーの主力製品
  • 企業合併・買収 (M&A)、拡大

第3章 ヒトオリゴミルク糖 (HMO)：地域別の現状と展望

  • 世界のヒトオリゴミルク糖 (HMO) の市場規模・CAGR：地域別 (2017年・2021年・2028年)
  • 過去の市場規模：地域別
  • 市場規模の予測：地域別

第4章 ヒトオリゴミルク糖 (HMO)：用途別

  • 用途別の市場セグメント
    • 乳児用調製粉乳
    • 機能性食品・飲料
    • 食品用/医療用サプリメント、その他
  • 用途別の市場規模
    • 市場規模の概要：用途別 (2017年～2028年)
    • 過去の市場規模：用途別 (2017年～2022年)
    • 市場規模の予測：用途別 (2023年～2028年)
  • 主要地域の市場規模：用途別
    • 北米のヒトオリゴミルク糖 (HMO) の販売：用途別 (2017年～2022年)
    • 欧州のヒトオリゴミルク糖 (HMO) の販売：用途別 (2017年～2022年)
    • アジア太平洋のヒトオリゴミルク糖 (HMO) の販売：用途別 (2017年～2022年)

第5章 北米のヒトオリゴミルク糖 (HMO)：国別

  • 過去の市場規模：国別
  • 市場規模の予測：国別

第6章 欧州のヒトオリゴミルク糖 (HMO)：国別

第7章 アジア太平洋のヒトオリゴミルク糖 (HMO)：地域別

第8章 企業プロファイル：ヒトオリゴミルク糖 (HMO) 事業の主要指標

  • ABBOTT
  • INBIOSE
  • GLYCOM
  • CHR. HANSEN (JENNEWEIN)
  • ELICITYL SA
  • ZUCHEM

第9章 上流工程・機会・課題・リスク・影響要因の分析

  • ヒトオリゴミルク糖 (HMO) の主要原材料
  • 製造コストの構造
  • ヒトオリゴミルク糖 (HMO) の産業チェーンの分析
  • ヒトオリゴミルク糖 (HMO) の市場力学

第10章 マーケティング戦略分析、流通業者

  • 販売チャンネル
  • ヒトオリゴミルク糖 (HMO) の流通業者
  • ヒトオリゴミルク糖 (HMO) の下流工程の顧客

第11章 調査結果と結論

第12章 付録

図表

LIST OF TABLES

  • Table 1. Global Human Milk Oligosaccharides (HMO) Sales by Type: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Global Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
  • Table 3. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type (2017-2022)
  • Table 4. Global Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (US$ Million)
  • Table 5. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type (2017-2022)
  • Table 6. Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022) & (USD/Kg)
  • Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
  • Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type (2023-2028)
  • Table 9. Global Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (US$ Million)
  • Table 10. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type (2023-2028)
  • Table 11. Global Human Milk Oligosaccharides (HMO) Price by Type (2023-2028) & (USD/Kg)
  • Table 12. North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
  • Table 13. North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (US$ Million)
  • Table 14. Europe Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2017-2022)
  • Table 15. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (US$ Million)
  • Table 16. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2017-2022)
  • Table 17. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (US$ Million)
  • Table 18. Global Human Milk Oligosaccharides (HMO) Sales by Company (2018-2022) & (Tons)
  • Table 19. Global Human Milk Oligosaccharides (HMO) Sales Share by Company (2018-2022)
  • Table 20. Global Human Milk Oligosaccharides (HMO) Revenue by Company (2018-2022) & (US$ Million)
  • Table 21. Global Human Milk Oligosaccharides (HMO) Revenue Share by Company (2018-2022)
  • Table 22. Global Market Human Milk Oligosaccharides (HMO) Price by Company (2018-2022) & (USD/Kg)
  • Table 23. Date of Key Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
  • Table 24. Key Manufacturers Human Milk Oligosaccharides (HMO) Product Type
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 27. Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (Tons)
  • Table 28. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Region (2017-2022)
  • Table 29. Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (US$ Million)
  • Table 30. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2017-2022)
  • Table 31. Global Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Region (2017-2022)
  • Table 32. Global Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (Tons)
  • Table 33. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Region (2023-2028)
  • Table 34. Global Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (US$ Million)
  • Table 35. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2023-2028)
  • Table 36. Global Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Region (2023-2028)
  • Table 37. Global Human Milk Oligosaccharides (HMO) Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 38. Global Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
  • Table 39. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application (2017-2022)
  • Table 40. Global Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (US$ Million)
  • Table 41. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application (2017-2022)
  • Table 42. Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022) & (USD/Kg)
  • Table 43. Global Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
  • Table 44. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application (2023-2028)
  • Table 45. Global Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (US$ Million)
  • Table 46. Global Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application (2023-2028)
  • Table 47. Global Human Milk Oligosaccharides (HMO) Price by Application (2023-2028) & (USD/Kg)
  • Table 48. North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
  • Table 49. North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (US$ Million)
  • Table 50. Europe Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2017-2022)
  • Table 51. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (US$ Million)
  • Table 52. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2017-2022)
  • Table 53. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (US$ Million)
  • Table 54. North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
  • Table 55. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Country (2017-2022)
  • Table 56. North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (US$ Million)
  • Table 57. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Country (2017-2022)
  • Table 58. North America Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
  • Table 59. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Country (2023-2028)
  • Table 60. North America Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (US$ Million)
  • Table 61. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Country (2023-2028)
  • Table 62. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
  • Table 63. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Country (2017-2022)
  • Table 64. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (US$ Million)
  • Table 65. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Country (2017-2022)
  • Table 66. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
  • Table 67. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Country (2023-2028)
  • Table 68. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (US$ Million)
  • Table 69. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Country (2023-2028)
  • Table 70. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (Tons)
  • Table 71. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volumeby Region (2017-2022)
  • Table 72. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (US$ Million)
  • Table 73. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2017-2022)
  • Table 74. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (Tons)
  • Table 75. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Region (2023-2028)
  • Table 76. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (US$ Million)
  • Table 77. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Region (2023-2028)
  • Table 78. Abbott Corporation Information
  • Table 79. Abbott Introduction and Business Overview
  • Table 80. Abbott Human Milk Oligosaccharides (HMO) Sales (Ton), Revenue (Million US$), Price (USD/kg) and Gross Margin (2018-2022)
  • Table 81. Abbott Human Milk Oligosaccharides (HMO) Product
  • Table 82. Abbott Recent Development
  • Table 83. Inbiose Corporation Information
  • Table 84. Inbiose Introduction and Business Overview
  • Table 85. Inbiose Human Milk Oligosaccharides (HMO) Sales (Ton), Revenue (Million US$), Price (USD/kg) and Gross Margin (2018-2022)
  • Table 86. Inbiose Human Milk Oligosaccharides (HMO) Product
  • Table 87. Inbiose Recent Development
  • Table 88. Glycom Corporation Information
  • Table 89. Glycom Introduction and Business Overview
  • Table 90. Glycom Human Milk Oligosaccharides (HMO) Sales (Ton), Revenue (Million US$), Price (USD/kg) and Gross Margin (2018-2022)
  • Table 91. Glycom Human Milk Oligosaccharides (HMO) Product
  • Table 92. Glycom Recent Development
  • Table 93. Chr. Hansen (Jennewein) Corporation Information
  • Table 94. Chr. Hansen (Jennewein) Introduction and Business Overview
  • Table 95. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Ton), Revenue (Million US$), Price (USD/kg) and Gross Margin (2018-2022)
  • Table 96. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product
  • Table 97. Chr. Hansen (Jennewein) Recent Development
  • Table 98. Elicityl SA Corporation Information
  • Table 99. Elicityl SA Introduction and Business Overview
  • Table 100. Elicityl SA Human Milk Oligosaccharides (HMO) Product
  • Table 101. ZuChem Corporation Information
  • Table 102. ZuChem Introduction and Business Overview
  • Table 103. ZuChem Human Milk Oligosaccharides (HMO) Product
  • Table 104. ZuChem Recent Development
  • Table 105. Key Raw Materials Lists
  • Table 106. Human Milk Oligosaccharides (HMO) Market Trends
  • Table 107. Human Milk Oligosaccharides (HMO) Market Drivers
  • Table 108. Human Milk Oligosaccharides (HMO) Market Challenges
  • Table 109. Human Milk Oligosaccharides (HMO) Distributors List
  • Table 110. Human Milk Oligosaccharides (HMO) Downstream and Potential Customers
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Human Milk Oligosaccharides (HMO) Product Picture
  • Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size Status and Outlook (2017-2028) & (US$ Million)
  • Figure 3. Global Human Milk Oligosaccharides (HMO) Sales Status and Outlook (2017-2028) & (Tons)
  • Figure 4. Global 2'-FL & 3-FL Sales YoY Growth (2017-2028) & (Tons)
  • Figure 5. Global Sialyllactose, LNT & LNnT, etc. Sales YoY Growth (2017-2028) & (Tons)
  • Figure 6. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2021
  • Figure 7. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2021
  • Figure 8. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2021
  • Figure 9. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2021
  • Figure 10. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Type in 2021
  • Figure 11. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Type in 2021
  • Figure 12. Product Picture of Infant Formula
  • Figure 13. Product Picture of Functional Food & Beverages
  • Figure 14. Product Picture of Food/Medical Supplements and Others
  • Figure 15. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2021
  • Figure 16. North America Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2021
  • Figure 17. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2021
  • Figure 18. Europe Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2021
  • Figure 19. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Volume by Application in 2021
  • Figure 20. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share in Value by Application in 2021
  • Figure 21. Human Milk Oligosaccharides (HMO) Manufacturing Cost Structure
  • Figure 22. Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
  • Figure 23. Channels of Distribution
  • Figure 24. Distributors Profiles
  • Figure 25. Bottom-up and Top-down Approaches for This Report
  • Figure 26. Data Triangulation
  • Figure 27. Key Executives Interviewed
目次

Market Analysis and Insights:

In 2021, the Global Human Milk Oligosaccharides (HMO) market size was valued at USD 378.52 Million, increased from USD 83.73 Million in 2017, and the market is forecasted to reach USD 1055.83 Million by 2028, growing at CAGR of 14.54% between 2022 and 2028.

The global main manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem, etc. In 2021, the global top 3 largest players have a share approximately 80.96% in terms of revenue.

Scope and Market Size:

The global Human Milk Oligosaccharides (HMO) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company

  • Abbott
  • Inbiose
  • Glycom
  • Chr. Hansen (Jennewein)
  • Elicityl SA
  • ZuChem

Segment by Type

  • 2'-FL & 3-FL
  • Sialyllactose, LNT & LNnT, etc.

Segment by Application

  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements, etc.

By Region

  • North America
    • U.S.
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Australia
    • Rest of APAC
  • Europe
    • Germany
    • UK
    • France
    • Belgium
    • Denmark
    • Rest of Europe
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET OVERVIEW

  • 1.1 HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCT OVERVIEW
  • 1.2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY TYPE
    • 1.2.1 2'-FL & 3-FL
    • 1.2.2 SIALYLLACTOSE, LNT & LNNT, ETC.
  • 1.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE BY TYPE
    • 1.3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE OVERVIEW BY TYPE (2017-2028)
    • 1.3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
    • 1.3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY TYPE (2023-2028)
  • 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
    • 1.4.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.3 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)

2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET COMPETITION BY COMPANY

  • 2.1 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) SALES (2018-2022)
  • 2.2 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) REVENUE (2018-2022)
  • 2.3 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE (2018-2022)
  • 2.4 DATE OF KEY MANUFACTURERS ENTER INTO HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET
  • 2.5 KEY MANUFACTURERS HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCT OFFERED
  • 2.6 MERGERS & ACQUISITIONS, EXPANSION

3 HUMAN MILK OLIGOSACCHARIDES (HMO) STATUS AND OUTLOOK BY REGION

  • 3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
  • 3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY REGION
    • 3.2.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2017-2022)
    • 3.2.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2017-2022)
    • 3.2.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE BY REGION (2017-2022)
  • 3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY REGION
    • 3.3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2023-2028)
    • 3.3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2023-2028)
    • 3.3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE BY REGION (2023-2028)

4 HUMAN MILK OLIGOSACCHARIDES (HMO) BY APPLICATION

  • 4.1 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY APPLICATION
    • 4.1.1 INFANT FORMULA
    • 4.1.2 FUNCTIONAL FOOD & BEVERAGES
    • 4.1.3 FOOD/MEDICAL SUPPLEMENTS AND OTHERS
  • 4.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE BY APPLICATION
    • 4.2.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
    • 4.2.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
    • 4.2.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
  • 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
    • 4.3.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.3.3 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)

5 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRY

  • 5.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY COUNTRY
    • 5.1.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2017-2022)
    • 5.1.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2017-2022)
  • 5.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY COUNTRY
    • 5.2.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2023-2028)
    • 5.2.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2023-2028)

6 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRY

  • 6.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY COUNTRY
    • 6.1.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2017-2022)
    • 6.1.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2017-2022)
  • 6.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY COUNTRY
    • 6.2.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2023-2028)
    • 6.2.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2023-2028)

7 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) BY REGION

  • 7.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY REGION
    • 7.1.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2017-2022)
    • 7.1.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2017-2022)
  • 7.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY REGION
    • 7.2.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2023-2028)
    • 7.2.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2023-2028)

8 COMPANY PROFILES AND KEY FIGURES IN HUMAN MILK OLIGOSACCHARIDES (HMO) BUSINESS

  • 8.1 ABBOTT
    • 8.1.1 ABBOTT CORPORATION INFORMATION
    • 8.1.2 ABBOTT INTRODUCTION AND BUSINESS OVERVIEW
    • 8.1.3 ABBOTT HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
    • 8.1.4 ABBOTT HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
    • 8.1.5 ABBOTT RECENT DEVELOPMENT
  • 8.2 INBIOSE
    • 8.2.1 INBIOSE CORPORATION INFORMATION
    • 8.2.2 INBIOSE INTRODUCTION AND BUSINESS OVERVIEW
    • 8.2.3 INBIOSE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
    • 8.2.4 INBIOSE HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
    • 8.2.5 INBIOSE RECENT DEVELOPMENT
  • 8.3 GLYCOM
    • 8.3.1 GLYCOM CORPORATION INFORMATION
    • 8.3.2 GLYCOM INTRODUCTION AND BUSINESS OVERVIEW
    • 8.3.3 GLYCOM HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
    • 8.3.4 GLYCOM HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
    • 8.3.5 GLYCOM RECENT DEVELOPMENT
  • 8.4 CHR. HANSEN (JENNEWEIN)
    • 8.4.1 CHR. HANSEN (JENNEWEIN) CORPORATION INFORMATION
    • 8.4.2 CHR. HANSEN (JENNEWEIN) INTRODUCTION AND BUSINESS OVERVIEW
    • 8.4.3 CHR. HANSEN (JENNEWEIN) HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
    • 8.4.4 CHR. HANSEN (JENNEWEIN) HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
    • 8.4.5 CHR. HANSEN (JENNEWEIN) RECENT DEVELOPMENT
  • 8.5 ELICITYL SA
    • 8.5.1 ELICITYL SA CORPORATION INFORMATION
    • 8.5.2 ELICITYL SA INTRODUCTION AND BUSINESS OVERVIEW
    • 8.5.3 ELICITYL SA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES
    • 8.5.4 ELICITYL SA HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
  • 8.6 ZUCHEM
    • 8.6.1 ZUCHEM CORPORATION INFORMATION
    • 8.6.2 ZUCHEM INTRODUCTION AND BUSINESS OVERVIEW
    • 8.6.3 ZUCHEM HUMAN MILK OLIGOSACCHARIDES (HMO) SALES
    • 8.6.4 ZUCHEM HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
    • 8.6.5 ZUCHEM RECENT DEVELOPMENT

9 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 9.1 HUMAN MILK OLIGOSACCHARIDES (HMO) KEY RAW MATERIALS
  • 9.2 MANUFACTURING COST STRUCTURE
    • 9.2.1 RAW MATERIALS
    • 9.2.2 LABOR COST
    • 9.2.3 MANUFACTURING EXPENSES
  • 9.3 HUMAN MILK OLIGOSACCHARIDES (HMO) INDUSTRIAL CHAIN ANALYSIS
  • 9.4 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
    • 9.4.1 INDUSTRY TRENDS
    • 9.4.2 MARKET DRIVERS
    • 9.4.3 MARKET CHALLENGES

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 10.1 SALES CHANNEL
  • 10.2 HUMAN MILK OLIGOSACCHARIDES (HMO) DISTRIBUTORS
  • 10.3 HUMAN MILK OLIGOSACCHARIDES (HMO) DOWNSTREAM CUSTOMERS

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

  • 12.1 RESEARCH METHODOLOGY
    • 12.1.1 METHODOLOGY/RESEARCH APPROACH
    • 12.1.2 DATA SOURCE
  • 12.2 AUTHOR DETAILS
  • 12.3 DISCLAIMER